<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font20 { font-size : 20; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font20">and </span>
   <span class="font14">The </span>
   <span class="font14">that </span>
   <span class="font14">{background </span>
   <span class="font14">TPBIA </span>
   <span class="font13">was </span>
   <span class="font13">with </span>
   <span class="font13">margin </span>
   <span class="font12">{border-style </span>
   <span class="font12">dopamine </span>
   <span class="font12">its </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">activity </span>
   <span class="font12">for </span>
   <span class="font11">antioxidant </span>
   <span class="font11">effects </span>
   <span class="font11">from </span>
   <span class="font11">were </span>
   <span class="font11">rats </span>
   <span class="font11">treatment </span>
   <span class="font11">free </span>
   <span class="font11">have </span>
   <span class="font11">Psychiatry </span>
   <span class="font11">agonist </span>
   <span class="font11">al. </span>
   <span class="font11">blood-brain </span>
   <span class="font11">has </span>
   <span class="font11">potential </span>
   <span class="font11">px; </span>
   <span class="font11">receptor </span>
   <span class="font11">tardive </span>
   <span class="font11">various </span>
   <span class="font11">vitamin </span>
   <span class="font11">{font-family </span>
   <span class="font11">Figure </span>
   <span class="font11">antipsychotic </span>
   <span class="font11">apomorphine </span>
   <span class="font11">are </span>
   <span class="font11">been </span>
   <span class="font11">behavior </span>
   <span class="font11">central </span>
   <span class="font11">could </span>
   <span class="font11">dyskinesia </span>
   <span class="font11">font-size </span>
   <span class="font11">lipid </span>
   <span class="font11">motor </span>
   <span class="font11">neuroleptic </span>
   <span class="font11">peroxidation </span>
   <span class="font11">study </span>
   <span class="font11">this </span>
   <span class="font11">treated </span>
   <span class="font11">well </span>
   <span class="font11">which </span>
   <span class="font10">compounds </span>
   <span class="font10">concentrations </span>
   <span class="font10">double; </span>
   <span class="font10">experimental </span>
   <span class="font10">found </span>
   <span class="font10">increased </span>
   <span class="font10">molecular </span>
   <span class="font10">rats, </span>
   <span class="font10">surface </span>
   <span class="font10">vitro </span>
   <span class="font10">(Figure </span>
   <span class="font10">-HT </span>
   <span class="font10">Lohr </span>
   <span class="font10">PSA </span>
   <span class="font10">TPBIA. </span>
   <span class="font10">Tardive </span>
   <span class="font10">This </span>
   <span class="font10">acid </span>
   <span class="font10">activity. </span>
   <span class="font10">area </span>
   <span class="font10">barrier </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">compound </span>
   <span class="font10">group </span>
   <span class="font10">induced </span>
   <span class="font10">min </span>
   <span class="font10">molecule </span>
   <span class="font10">non </span>
   <span class="font10">not </span>
   <span class="font10">partial </span>
   <span class="font10">receptors </span>
   <span class="font10">related </span>
   <span class="font10">results </span>
   <span class="font10">shown </span>
   <span class="font10">side </span>
   <span class="font10">solid; </span>
   <span class="font10">studies </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Demopoulos </span>
   <span class="font10">H-benz </span>
   <span class="font10">PBIA </span>
   <span class="font10">Vitamin </span>
   <span class="font10">Waals </span>
   <span class="font10">absorption </span>
   <span class="font10">according </span>
   <span class="font10">affinity </span>
   <span class="font10">agent </span>
   <span class="font10">antagonist </span>
   <span class="font10">antagonistic </span>
   <span class="font10">behavioral </span>
   <span class="font10">between </span>
   <span class="font10">binding </span>
   <span class="font10">bold </span>
   <span class="font10">cage </span>
   <span class="font10">can </span>
   <span class="font10">courier; </span>
   <span class="font10">der </span>
   <span class="font10">effect </span>
   <span class="font10">em; </span>
   <span class="font10">energy </span>
   <span class="font10">important </span>
   <span class="font10">low </span>
   <span class="font10">model </span>
   <span class="font10">nervous </span>
   <span class="font10">oxidative </span>
   <span class="font10">polar </span>
   <span class="font10">previous </span>
   <span class="font10">profile </span>
   <span class="font10">properties </span>
   <span class="font10">pt;} </span>
   <span class="font10">radical </span>
   <span class="font10">rats: </span>
   <span class="font10">receptors. </span>
   <span class="font10">since </span>
   <span class="font10">their </span>
   <span class="font10">van </span>
   <span class="font10">vdem@pharm.auth.gr </span>
  </p>
 </body>
</html>
